VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments
Journal of Clinical Medicine · 19.11.2024 · 13 (22) · 6970
DOI: 10.3390/jcm13226970 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.11.2024. Verfasst von Safi Alqatari und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Division, Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
VEXAS syndrome is a recently identified autoinflammatory disorder resulting from somatic mutations in the UBA1 gene, leading to a complex spectrum of severe inflammatory and hematologic manifestations. The absence of established treatment guidelines and the variability in clinical presentation make its management particularly challenging. Current therapeutic approaches are often based on limited evidence, and their effectiveness remains inconsistent. This review seeks to consolidate the existing knowledge on therapeutic strategies for VEXAS syndrome, offering a critical evaluation of their efficacy and addressing the gaps in the current literature. As the clinical recognition of VEXAS grows, there is an urgent need to explore more targeted, effective treatments that can address both the inflammatory and hematologic aspects of the disease. By providing a comprehensive analysis of the current therapeutic landscape, this review aims to guide clinicians and researchers toward developing more effective, long-term management strategies for this life-threatening condition.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology Division, Department of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
- College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
ORCID-Profile: Safi Alqatari, Shahad M Alali, Mohammed A Alharbi, Manal Hasan, Mohammed D Al Shubbar
Zitieren
APA
Alqatari, S., Alqunais, A. A., Alali, S. M., Alharbi, M. A., Hasan, M., & Al Shubbar, M. D. (2024). VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments. Journal of Clinical Medicine, 13(22), 6970. https://doi.org/10.3390/jcm13226970
Vancouver
Alqatari S, Alqunais AA, Alali SM, Alharbi MA, Hasan M, Al Shubbar MD. VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments. Journal of Clinical Medicine. 2024;13(22):6970. doi:10.3390/jcm13226970
BibTeX
@article{Alqatari2024,
author = {Alqatari, Safi and Alqunais, Abdulaziz A and Alali, Shahad M and Alharbi, Mohammed A and Hasan, Manal and Al Shubbar, Mohammed D},
title = {VEXAS Syndrome: A Comprehensive Review of Current Therapeutic Strategies and Emerging Treatments},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {22},
pages = {6970},
doi = {10.3390/jcm13226970}
}
EUVIMED